# Inspire Medical Systems, Inc. to Present at the Piper Sandler 38th Annual Healthcare Conference

- Published: 2026-11-17
- Author: [Healthcare News](https://healthcarenews.io/author/healthcarenews-io.md)
- Topics: [News](https://healthcarenews.io/news.md)
- Source: https://healthcarenews.io/news/inspire-medical-systems-inc-to-present-at-the-piper-sandler-38th-annual-healthcare-confere/
- Publication: Healthcare News
- Publisher: Connectively (Terkel, Inc.)
- Editorial policy: https://healthcarenews.io/editorial-policy/

MINNEAPOLIS, Nov. 17, 2026 [(GLOBE NEWSWIRE)](https://www.globenewswire.com) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Piper Sandler 38th Annual Healthcare Conference on Tuesday, December 1, 2026.

Inspire is scheduled to present at 3:00 p.m. Eastern Time. The presentation will be accessible via a live webcast <a href="https://www.globenewswire.com/Tracker?data=elgbCQjUrh_0oh3Pa_oLKFTqzpFpCxRpudc2hmRbkBD06DKBQHwejQzeEu2nFn3f0b4_rjhd-eb2PwT3ykAxANH-fef4R7XKknWnq8EFJxxqGf_O9rOZySxKy9_wRnek9zJbWQMByTBwEyoHFFW3Mw==" rel="nofollow">here</a>.

A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at <a href="https://www.globenewswire.com/Tracker?data=00YGQ7dAyt_HWvfpaZ2UfvwwbQcUfv-31RfLBMmr-qKKXwl0_XjB3XuzIykOdDuYd5n5P87Wzw6gdZvJNkDdXB0XnvHLyi7pxOpU7DmJJZ9EFcOh_WtAvIJRR_5FLZlqQzI_bZkY5Iv8bqudoYXczTaqrt1DXyy16eZPCwvO1L9eQTcBRGYNbJBkDV5L_ugaDazN3PdxNBq11rvNipnLY1Q-tMNpqojbWVzqEYkhFZSHj0LUtIFt1w5a-2Sjn51HYAuNOn59qpIT9WUazxC-mEpCsFvLzM8tJ2npnzwaXMHj59YdbDl88QGSqScKhNakEbi42ujv5DFZo3eXbGpqDS9rQLwhao9WiU2k77vxbSxlFsCZ-WqiwoLH9KBZ0tsNMV1MMa2dV3jjvkWJe6yHwvYQUOHwvE4cGg9dU4XMFP52RhrZyomKrSIplQxxKLAJ7W_P5fsipKXeML7OInSayA==" rel="nofollow">https://investors.inspiresleep.com</a>.

**About Inspire Medical Systems**  
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit <a href="https://www.globenewswire.com/Tracker?data=XtzynufBxkaJ3R7fVR5yGrnSJTCSYC77EJHACZkNQkCX7wlv76vYWNY7OrQ6HUdtjMdWfoM9dPQAVjAp4zwFeVjDh_w3opgwe3X2T7om-uV1dezfHeNpoyfkgdzSv2lCHXc0u7Xdu8vCgeyr6MlL9Fw0tT5K-cU1dZQCJCwXTyUIk_ZqUrKJ053E8YY5mEruM_EY4J94-IHZ6Fmk-U32qNkNOeWfZDReAW03zxNlpCefDwZo13NUdtp0yM1veIXN51gi3vPsVYFQWLaE3pHXwvRdsDS5ykQ5Bq_XPp_3nEnA1Jl2Sf3GqvwJbiyTVYqTgIbHFBghWtdNgJKXy500RH87lutRVFDOi_HRIfgjAafAWyMGfx433t22cvy1eXkCPDkvzEtVVJRWwy0yUEHmCxKEg4hac9brKOZWudj8jTh0R6woUPPnzHo4EHSKJZ0-" rel="nofollow">www.inspiresleep.com</a>.

**Investor Contact**  
Brian Johnston or Louisa Smith  
Gilmartin Group, LLC  
<a href="https://www.globenewswire.com/Tracker?data=u8XtoXPXElqXe0jKrM6WpYw4-YWRI94z9dtAb-Au5I6NpP1fMHbTtiR0Z7nu0vWhH4jfOufCTBPT4q-8Ut26HbVgO1S8FaJMG-M5HSOg3wQ=" rel="nofollow">IR@inspiresleep.com</a>

  
![](https://ml.globenewswire.com/media/YzY0OWRkYzYtMmVhNC00MDFiLTkwZGEtMjYxYzY5OTdlNDk2LTExODkzODUtMjAyNi0xMS0xNy1lbg==/tiny/Inspire-Medical-Systems.png)

## Related

- [Generic Nexletol and Nexlizet: a seventh drugmaker agrees to wait until 2040](https://healthcarenews.io/news/generic-nexletol-2040-seventh-settlement.md)
- [Medicare counted 6,436 surgery centers in 2024. Trimedx now offers them equipment maintenance nationwide](https://healthcarenews.io/news/surgery-center-equipment-maintenance-trimedx-nationwide.md)
- [Novartis again leads drugmakers on reaching patients in poorer countries in the 2026 Access to Medicine Index](https://healthcarenews.io/news/2026-access-to-medicine-index-novartis-ranks-first.md)
- [Glanzmann thrombasthenia has no approved preventive treatment. A weekly injection enters its final-stage trial](https://healthcarenews.io/news/glanzmann-thrombasthenia-treatment-weekly-injection-phase-3.md)
